Skip to main contentrtttttt Skip to main content
Integrative Psychiatry

Poetry Prescriptions: Poetry in Mental Health

By October 28, 2024No Comments

Let this darkness be a bell tower

and you the bell. As you ring,

what batters you becomes your strength.

-excerpt from “Let this Darkness Be a Bell Tower” by Rainer Maria Rilke

We are all artists. It is human nature to express ourselves through creation. In fact, we are neurologically wired to respond to and make meaning out of symbols. Sometimes, pain is nonverbal and we are “at a loss for words.” Poetry, like music, has a way of filling that gap, articulating the unarticulated through imagery and sound rather than narrative. Self-expression through visualization, emotional depth, cadence, and energetic release has positive effects on both the mind and body. 

Healing Benefits of Poetry

Part of the beauty of poetry lies in its accessibility. There is no one way to engage with poetry, so it can be tailored to our specific needs in each moment. There is freedom in choice. We can search for a poem that has been written by someone else or create our own. A poem can be structured or unstructured, guided or unguided, collaborative or individual, written or vocalized, long or short, and anywhere in between. Yet whether it’s scribbling down feelings in short, unpolished lines or speaking from the heart, poetry can be profoundly moving. 

One therapeutic intention of writing poetry might be to give form to emotions in a way that fosters personal understanding and acceptance. Creating poetry allows us to process our experiences using our inner wisdom. While it might be challenging to name overwhelming feelings, poetry gives our inner state a form–something to look at, to listen to, to digest.

Likewise, sometimes it can be hard to communicate the felt sense of an emotion to another person. For example, grief and loss is challenging to convey in everyday conversation. However, a poem might help capture the emotional depths that can be shared. In this way, poetry enables empathy and connection between two or more people. But poetry doesn’t always have to be about negative emotions; it can also be used to establish and nurture positive feelings, too. Reading, reciting, and writing may be used as a tool to notice the nourishment of joy, gratitude, awe, and love around us.

The Nonverbal Brain

While the emotional benefits of poetry are intuitive, there’s also fascinating science to explain how poetry affects the brain. Studies show that reading or writing poetry stimulates both the left and right hemispheres of the brain. This “bilateral stimulation” is an important aspect of therapy, especially trauma work, because it integrates feeling into something that can be assessed by the executive networks of the brain. In other words, bilateral stimulation helps us make sense of ourselves. 

Researchers also believe that reading and writing poetry alters activity in the default mode network (DMN), a brain region associated with self-reflection, daydreaming, and memory consolidation. When we’re absorbed in a poem, our brains naturally shift states, allowing for introspection. This is why many people find that poetry helps them better understand themselves and their feelings. 

Reading or writing poetry in a mindful, intentional way can also help soothe the nervous system. The cathartic and often rhythmic nature of poetry helps engage the parasympathetic nervous system, which is responsible for rest and relaxation. In turn, breathing is regulated and heart rate is slowed. This system helps counteract the fight-or-flight response triggered by stress and anxiety, promoting a state of relaxation and recovery.

In fact, poetry might be compared to meditation because of its ability to promote mindfulness. When we’re fully immersed in a poem, we’re not thinking about the past or worrying about the future—we are present, in the moment. Mindfulness that is focused on emotional resourcing can help establish a sense of groundedness and “okayness.”

Poetry In Action

Expressive writing is one way to explore emotions therapeutically. The idea behind this free-form modality is to let go of judgements about what poetry is or is not. Adding sensory experiences might be helpful here, identifying sights, sounds, smells, tastes, and touch that relate to internal thoughts and feelings.

My own practice of poetry involves nature. I like to sit outside, sitting in a brief meditation, before looking around and describing what I see. I am continually surprised by how what I write relates to my psyche. My projections are undeniably present in my work; my inner landscape disguised as descriptions of the outer scene. 

Vocalizing poetry is yet another avenue for therapeutic healing. Sharing art is a vulnerable act. Fear of rejection and desire for belonging can arise in this space of reciprocal giving and receiving; intimate connections are harvested in collective validation and support of a person’s bravery. Additionally, performances that encourage fluctuation and emphasis, and movement–giving life to the poetry–can impart a bodily sense of empowerment and aliveness. Spoken word, for example, is like speaking truth from the center of our souls.

Conclusion

Reading, writing, and speaking poetry may be used in a variety of ways to support wellbeing. In general, I think poetry is an act of resilience. By creating, we can shift emotional states, find meaning, see new perspectives, rewrite our own stories, and cope with stressors.

Sara Reed, MS, LMFT

Sara Reed is a Licensed Marriage and Family Therapist and CEO of Mind’s iHealth Solutions, a digital health company that provides evidence based and culturally responsible mental health services for underserved groups. As a mental health futurist and clinical researcher, Sara examines the ways culture informs the way we diagnose and treat mental illness. Sara’s prior research work includes participation as a study therapist in psychedelic therapy research at Yale University and the University of Connecticut’s Health Center. Sara was the first Black therapist to provide MDMA-assisted psychotherapy in a clinical trial and continues to engage in ongoing advocacy work around health equity in psychedelic medicine.

https://psychiatryinstitute.com/wp-content/uploads/2019/11/Jeffrey-Guss.png

Jeffrey Guss, MD is a psychiatrist, psychoanalyst, and researcher with specializations in psychoanalytic therapy and the treatment of substance use disorders. He was Co-Principal Investigator and Director of Psychedelic Therapy Training for the NYU School of Medicine’s study on psychedelic-assisted psychotherapy in the treatment of cancer-related existential distress, which was published in Journal of Psychopharmacology, 2016. He currently is a study therapist in the NYU study on Psychedelic-Assisted therapy in the treatment of Alcoholism, a collaborator with Yale University’s study on psychedelic-assisted therapy for Major Depressive Disorder and a study therapist with the MAPS (Multidisciplinary Association for Psychedelic Studies) study on treatment of Post Traumatic Stress Disorder with Psychedelic-Assisted Psychotherapy. 

Dr. Guss is interested in the integration of psychedelic therapies with contemporary psychoanalytic theory and has published in Studies in Gender and Sexuality and Psychoanalysis, Culture and Society. He has published (with Elizabeth Nielson, PhD) a paper on “the influence of therapists’ first had experience with psychedelics on psychedelic-assisted psychotherapy research and therapist training” in The Journal of Psychedelic Studies, August, 2018. He is an Instructor and Mentor with the California Institute of Integral Studies’ Center for Psychedelic Therapies and Supervisor in NYU’s Fellowship in Addiction Psychiatry. 

Dr. Guss maintains a private practice in New York City.

Will Van Derveer, MD

Will Van Derveer, MD is Co-Founder of Integrative Psychiatry Institute and Integrative Psychiatry Centers. Dr. Van Derveer was co-investigator on a phase 2 MAPS study of Psychedelic-assisted psychotherapy for treatment-resistant PTSD, and co-authored the publication of this study in 2018. He has also provided Psychedelic-assisted psychotherapy in two MAPS training studies. An active provider of KAP at his clinic in Boulder, CO, he has been teaching others KAP therapy for several years. Dr. Van Derveer contributed a chapter on mescaline in the 2021 "Handbook of Medical Hallucinogens" (edited by Charles Grob and Jim Grigsby). He is co-host of the Higher Practice Podcast.

Dr. Van Derveer regards unresolved emotional trauma as the most significant under-recognized root cause of psychiatric symptoms in integrative psychiatry practice, along with gut issues, hormone imbalances, inflammation, mitochondrial dysfunction, and other functional medicine challenges. He is trained in Somatic Experiencing, EMDR, Internal Family Systems, and other psychotherapy techniques. His current clinical passion is psychedelic-assisted psychotherapy, which he mentors interested doctors in providing. An avid meditator, he has been a meditation instructor since 2004.

For the past several years Dr. Van Derveer has taught psychiatrists and other psychiatric providers integrative psychiatry in a number of settings, including course directing the CU psychiatry residents’ course as well as with Scott Shannon and Janet Settle at the Psychiatry MasterClass.


Scott has been a student of consciousness since his honors thesis on that topic at the University of Arizona in the 1970s under the tutelage of Dr. Andrew Weil. Following medical school, Scott studied Jungian therapy and acupuncture while working as a primary care physician in a rural area for four years. Psychedelic-assisted psychotherapy became a facet of his practice before this medicine was scheduled in 1985. He then completed a psychiatry residency at Columbia program in New York. Scott studied cross-cultural psychiatry and completed a child/adolescent psychiatry fellowship at the University of New Mexico.

In 2010 he founded Wholeness Center in Fort Collins. This innovative clinic provides cross-disciplinary evaluation and care for all mental health concerns. Scott serves as a site Principal Investigator and therapist for the Phase III trial of psychedelic-assisted psychotherapy for PTSD sponsored by (MAPS). He has also published numerous articles about his research on (CBD) in mental health. Currently, Scott works extensively with psychedelic-assisted-psychotherapy. He lectures all over the world to professional groups interested in a deeper look at mental health issues, safer tools, and a paradigm-shifting perspective about transformative care.

Will Van Derveer, MD is co-founder of Integrative Psychiatry Institute (IPI), along with friend and colleague Keith Kurlander, MA. He co-created IPI as an expression of what he stands for. First, that anyone can heal, and second that we medical providers must embrace our own healing journeys in order to fully command our potency as healers.

Dr. Van Derveer spent the last 20 years innovating and testing a comprehensive approach to addressing psychiatric challenges which transcends the conventional model he learned in medical school at Vanderbilt University and residency at University of Colorado, while deeply engaging his own healing path.

He founded the Integrative Psychiatric Healing Center in in 2001 in Boulder, CO, where he currently practices. Dr. Van Derveer regards unresolved emotional trauma as the most significant root cause of psychiatric symptoms in integrative psychiatry practice, along with gut issues, hormone imbalances, inflammation, mitochondrial dysfunction, and other functional medicine challenges. He is trained in Somatic Experiencing, EMDR, Internal Family Systems, and other psychotherapy techniques. His current clinical passion is psychedelic-assisted psychotherapy, which he mentors interested doctors in providing. An avid meditator, he has been a meditation instructor since 2004.

For the past several years Dr. Van Derveer has taught psychiatrists and other psychiatric providers integrative psychiatry in a number of settings, including course directing the CU psychiatry residents’ course as well as with Scott Shannon and Janet Settle at the Psychiatry MasterClass. In addition to his clinical work and teaching, he was co-investigator in 2016 a Phase II randomized clinical trial, sponsored by the Multidisciplinary Association for Psychedelic Studies (MAPS). He continues to support this protocol, now in a Phase III clinical trial under break-through designation by FDA.

Dr. Van Derveer is a diplomate of the American Board of Integrative and Holistic Medicine (ABoIHM) since 2013, and he was board certified in the first wave of diplomates of the new American Board of Integrative Medicine (ABIM) in 2016.